Android Apple

Y-mAbs Therapeutics, Inc. (YMAB) Latest News

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$8.31

south_east -$0.27 (-3.09%)
Day's range
$8
Day's range
$8.47

Latest News of YMAB

Y-mAbs Therapeutics Inc (YMAB) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ...

Y-mAbs Therapeutics Inc (YMAB) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ...

By Yahoo! Finance | 1 month ago
While shareholders of Y-mAbs Therapeutics (NASDAQ:YMAB) are in the black over 1 year, those who bought a week ago aren't so fortunate

While shareholders of Y-mAbs Therapeutics (NASDAQ:YMAB) are in the black over 1 year, those who bought a week ago aren't so fortunate

By Yahoo! Finance | 2 months ago
Y-mAbs Therapeutics, Inc. (YMAB): One of Caligan Partners' Top Holdings Now?

Y-mAbs Therapeutics, Inc. (YMAB): One of Caligan Partners' Top Holdings Now?

By Yahoo! Finance | 4 months ago
We're Not Worried About Y-mAbs Therapeutics' (NASDAQ:YMAB) Cash Burn

We're Not Worried About Y-mAbs Therapeutics' (NASDAQ:YMAB) Cash Burn

By Yahoo! Finance | 5 months ago
close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.